AstraZeneca wins European approval for yet more of its cancer treatments
- Firm gets EU nod for three therapies- Imfinzi already a 'blockbuster' in sales terms- News caps an impressive share price performanceFTSE 100 pharmaceutical giant AstraZeneca (AZN) released a slew of positive news regarding trial...
19 December 2022